Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis

Citation
D. Berg et al., Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis, BL COAG FIB, 10(7), 1999, pp. 435-438
Citations number
18
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
BLOOD COAGULATION & FIBRINOLYSIS
ISSN journal
09575235 → ACNP
Volume
10
Issue
7
Year of publication
1999
Pages
435 - 438
Database
ISI
SICI code
0957-5235(199910)10:7<435:CFSAFA>2.0.ZU;2-O
Abstract
Chronic Fatigue and/or Fibromyalgia have long been diseases without definit ion. An explanatory model of coagulation activation has been demonstrated t hrough use of the ISAC panel of five tests, including, Fibrinogen, Prothrom bin Fragment 1+2, Thrombin/AntiThrombin Complexes, Soluble Fibrin Monomer, and Platelet Activation by flow cytometry. These tests show low level coagu lation activation from immunoglobulins (Igs) as demonstrated by Anti-B(2)GP I antibodies, which allows classification of these diseases as a type of an tiphospholipid antibody syndrome. The ISAC panel allows testing for diagnos is as well as monitoring for anticoagulation protocols in these patients. ( C) 1999 Lippincott Williams & Wilkins.